Literature DB >> 18467449

Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines.

Ruey-Nan Chen1, Ya-Hui Huang, Ya-Chu Lin, Chau-Ting Yeh, Ying Liang, Shen-Liang Chen, Kwang-Huei Lin.   

Abstract

The objective of this study was to identify genes regulated by thyroid hormone (T(3)) and associated with tumor invasion. The gene encoding furin, as previously identified by cDNA microarray, is known to be up-regulated by T(3) treatment, and stimulated furin production occurs in thyroidectomized rats after administration of T(3). Presently, by using serial deletion of the promoter and EMSAs, the T(3) response element on the furin promoter was localized to the -6317/-6302 region. T(3)-mediated furin up-regulation was cooperative with TGF-beta because T(3) induction increased after Smad3/4 addition. Furthermore, the invasiveness of HepG2-thyroid hormone receptor (TR) cells was significantly increased by T(3) treatment, perhaps due to furin processing of matrix metalloproteinase-2 and -9. In addition, furin up-regulation either by stable overexpression or T(3) and/or TGF-beta induction was evident in severe-combined immune-deficient mice inoculated with HepG2-TRalpha1 cells. The HepG2-furin mice displayed a higher metastasis index and tumor size than HepG2-neo mice. Notably, the increased liver and lung tumor number or size in the hyperthyroid severe-combined immune-deficient mice as well as TGF-beta mice was attributed specifically to furin overexpression in the HepG2-TRalpha1 cells. Furthermore, this study demonstrated that furin overexpression in some types of hepatocellular carcinomas is TR dependent and might play a crucial role in the development of hepatocellular carcinoma. Thus, T(3) regulates furin gene expression via a novel mechanism or in cooperation with TGF-beta to enhance tumor metastasis in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467449      PMCID: PMC2488248          DOI: 10.1210/en.2007-0989

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

Review 2.  Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors.

Authors:  S Y Cheng
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 3.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

4.  Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation.

Authors:  L D Miller; K S Park; Q M Guo; N W Alkharouf; R L Malek; N H Lee; E T Liu; S Y Cheng
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 5.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

6.  Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.

Authors:  F Blanchette; N Rivard; P Rudd; F Grondin; L Attisano; C M Dubois
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

7.  Direct production of an activated matrix metalloproteinase-9 (gelatinase B) from mammalian cells.

Authors:  Y Watanabe; K Hirakawa; T Haruyama; T Akaike
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

Review 8.  The proprotein convertases furin and PACE4 play a significant role in tumor progression.

Authors:  D E Bassi; H Mahloogi; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  2000-06       Impact factor: 4.784

9.  Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.

Authors:  D E Bassi; R Lopez De Cicco; H Mahloogi; S Zucker; G Thomas; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

10.  Elevated furin expression in aggressive human head and neck tumors and tumor cell lines.

Authors:  D E Bassi; H Mahloogi; L Al-Saleem; R Lopez De Cicco; J A Ridge; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  2001-08       Impact factor: 4.784

View more
  22 in total

1.  Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines.

Authors:  Sheng-Ming Wu; Ya-Hui Huang; Yi-Hsin Lu; Ling-Fang Chien; Chau-Ting Yeh; Ming-Ming Tsai; Chen-Hsin Liao; Wei-Jan Chen; Chia-Jung Liao; Wan-Li Cheng; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

2.  Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.

Authors:  Cheng-Yi Chen; Lang-Ming Chi; Hsiang-Cheng Chi; Ming-Ming Tsai; Chung-Ying Tsai; Yi-Hsin Tseng; Yang-Hsiang Lin; Wei-Jan Chen; Ya-Hui Huang; Kwang-Huei Lin
Journal:  Mol Cell Proteomics       Date:  2011-12-14       Impact factor: 5.911

3.  Novel oncogenic actions of TRbeta mutants in tumorigenesis.

Authors:  Celine J Guigon; Sheue-yann Cheng
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

Review 4.  Peptide processing and biology in human disease.

Authors:  Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

Review 5.  Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.

Authors:  Changxue Lu; Sheue-Yann Cheng
Journal:  J Mol Endocrinol       Date:  2009-09-09       Impact factor: 5.098

Review 6.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

7.  Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma.

Authors:  Ya-Hui Huang; Kwang-Huei Lin; Chen-Hsin Liao; Ming-Wei Lai; Yi-Hsin Tseng; Chau-Ting Yeh
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

8.  Liver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.

Authors:  Jeroen Declercq; Bas Brouwers; Vincent P E G Pruniau; Pieter Stijnen; Krizia Tuand; Sandra Meulemans; Annik Prat; Nabil G Seidah; Abdel-Majid Khatib; John W M Creemers
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

9.  Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.

Authors:  I-Hsiao Chung; Cheng-Yi Chen; Yang-Hsiang Lin; Hsiang-Cheng Chi; Ya-Hui Huang; Pei-Ju Tai; Chia-Jung Liao; Chung-Ying Tsai; Syuan-Ling Lin; Meng-Han Wu; Ching-Ying Chen; Kwang-Huei Lin
Journal:  Oncotarget       Date:  2015-06-20

Review 10.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.